氧合设备市场 - 全球产业规模、份额、趋势、机会及预测（按产品类型、应用、最终用户、地区和竞争格局划分，2021-2031年）

全球氧合设备市场预计将从 2025 年的 4.9 亿美元成长到 2031 年的 6.6 亿美元，复合年增长率为 5.09%。

这些专用医疗设备在心肺体外迴圈手术和体外膜氧合（ECMO）手术中至关重要，它们透过向静脉血中输送氧气并去除二氧化碳，暂时取代肺部的呼吸功能，然后再将血液送回动脉系统。全球范围内需要进行侵入性手术治疗的严重心血管疾病和呼吸衰竭的发生率不断上升，推动了该市场的发展。例如，根据美国心臟协会（AHA）2024年的报告，预计全球心血管疾病死亡人数将达到约1991万，凸显了对有效心肺支持技术的迫切需求。

儘管市场需求强劲，但由于医疗器材核准和品质保证方面的严格法规结构，该行业面临许多挑战。製造商必须应对复杂的合规标准，并进行广泛的临床试验以确保患者安全，此过程会显着延长产品开发週期。这些严格的要求推高了营运成本，提高了市场准入门槛，可能会减缓创新技术的商业化应用，并阻碍市场的快速扩张。

市场驱动因素

心血管和呼吸系统疾病的日益普遍正成为市场成长的主要催化剂，推动了冠状动脉绕道手术手术和心臟瓣膜修復等介入治疗的频率。随着这些慢性疾病负担的加重，需要临时心肺支持的手术数量也在增加，直接促进了人工肺的使用。主要临床註册机构的数据也印证了这一趋势；例如，胸腔外科医师协会报告称，截至2025年3月，其成人心臟外科手术资料库中已登记了超过830万例手术。持续的临床活动为主要製造商带来了可观的收入，Terumo Corporation于2025年5月公布的截至2025年3月的财年财务业绩（年销售额达1.362万亿日元）也证实了这些治疗方法强劲的商业性发展势头。

同时，体外膜氧合（ECMO）在临床上的日益普及，正将氧合设备的效用从传统手术室扩展到加护病房。医疗设备生物相容性的提升，使得医护人员能够更长时间地使用ECMO系统来治疗严重的急性呼吸衰竭和心臟麻痹，从而创造了清晰且快速增长的收入来源。生命支持技术的这种扩展应用也体现在全球註册资料中。根据体外生命支持组织（ELSO）的数据，截至2025年4月，累计记录的体外生命支持设备使用量已达245,291例，显示这些先进技术正被深度整合到重症监护通讯协定中。

市场挑战

全球氧气治疗设备市场目前面临许多挑战，主要源自于严格的设备核准和品质保证法规结构。儘管临床对心肺支援的需求日益增长，但将这些生命维持设备推向市场所需的复杂合规标准却构成了一大瓶颈。製造商被迫投入大量资源来满足这些严格的通讯协定，从而显着延长了从产品概念到上市的时间。这种延误扰乱了供应链，阻碍了先进氧气治疗技术及时交付给医疗机构。

此外，这些法规带来的经济负担提高了进入门槛，限制了市场扩张。企业被迫长期承担不断上涨的研发成本，却无法即时产生收入。根据欧洲医疗技术协会（MedTech Europe）预测，到2024年，根据现行法规，医疗设备审批的平均时间将为13至18个月。如此漫长的审批週期抑制了对新产品研发的投资，并给缺乏资金应对如此漫长审批流程的中小型创新企业带来了过重的负担，最终拖慢了整个行业的增长速度。

市场趋势

智慧氧合设备的出现正在改变市场格局，这些设备整合了感测器监测功能。它们能够增强复杂灌注手术过程中的临床决策。透过将即时感测功能直接整合到设备中，无需外部探头即可持续反馈氧饱和度、管路压力等关键参数。这种整合优化了灌注师的工作流程，并透过最大限度地减少手术室设备面积来提高操作效率。这些系统的商业性成功体现在 LivaNova PLC 截至 2024 年 10 月的财年财务业绩中，其中心肺支援设备业务的收入增长了 15.6%，主要得益于 Essenz 灌注系统及其耗材的销售。

同时，聚甲基戊烯（PMP）中空纤维膜技术正在取代传统的聚丙烯膜，尤其是在长期生命维持应用中。 PMP纤维具有卓越的抗血浆洩漏性能，使氧合器运作数天而非数小时。这满足了对长期体外膜氧合（ECMO）日益增长的需求。这项材料创新正在推动对耐用一次性产品的需求，即使在整体供应链中出现波动的情况下也是如此。例如，Getinge于2024年10月发布的2024年7月至9月中期报告指出，其心肺业务部门的耗材成长尤为显着，凸显了急诊护理领域对这些先进技术的持续依赖。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球氧合器市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品类型（鼓泡式氧合器与膜式氧合器）
  • 按类型（成人氧合器与儿童氧合器）
  • 依应用领域（呼吸系统、心臟系统、COVID-19、其他）
  • 按最终使用者（医院/诊所、门诊护理中心、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美氧合设备市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲氧气供应设备市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区氧合设备市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲氧合设备市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲氧合设备市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球氧合设备市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific, Inc.
• Siemens Healthcare GmbH
• Bio-Rad Laboratories, Inc.
• Koninklijke Philips NV
• Toshiba Corporation
• Agilent Technologies, Inc.
• Illumina, Inc.
• Merck KGaADanaher Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Oxygenators Market is projected to expand from USD 0.49 Billion in 2025 to USD 0.66 Billion by 2031, reflecting a CAGR of 5.09%. These specialized medical devices are essential during cardiopulmonary bypass surgeries and extracorporeal membrane oxygenation procedures, temporarily assuming the lung's respiratory functions by enriching venous blood with oxygen and removing carbon dioxide before returning it to the arterial system. The market's foundation rests on the rising global incidence of severe cardiovascular diseases and respiratory failures that require invasive surgical solutions. For instance, the American Heart Association reported in 2024 that cardiovascular disease caused approximately 19.91 million deaths worldwide, highlighting the urgent and escalating need for effective cardiopulmonary support technologies.

Despite this robust demand, the industry encounters significant hurdles due to stringent regulatory frameworks concerning device approval and quality assurance. Manufacturers must navigate complex compliance standards and conduct extensive clinical testing to guarantee patient safety, a process that considerably lengthens product development timelines. These exacting requirements escalate operational expenses and establish high barriers to entry, which can delay the commercial introduction of innovative technologies and hinder the market's rapid expansion.

Market Driver

The increasing prevalence of cardiovascular and respiratory diseases acts as a primary catalyst for market growth, driving a higher frequency of invasive interventions like coronary artery bypass grafting and heart valve repairs. As the burden of these chronic conditions grows, the number of surgical procedures necessitating temporary cardiopulmonary support has risen, directly boosting the use of oxygenators. This trend is supported by data from major clinical registries; for example, The Society of Thoracic Surgeons reported in March 2025 that their Adult Cardiac Surgery Database included over 8.3 million cumulative procedures. This sustained clinical activity drives substantial financial results for major manufacturers, as evidenced by Terumo Corporation, which reported an annual revenue of ¥1,036.2 billion in May 2025 for the fiscal year ending March 31, 2025, confirming the strong commercial momentum behind these therapies.

Concurrently, the wider clinical adoption of Extracorporeal Membrane Oxygenation (ECMO) is expanding the utility of oxygenators beyond traditional operating theaters into intensive care units. Improvements in device biocompatibility enable healthcare providers to use ECMO systems for extended periods to treat severe acute respiratory failure and cardiac arrest, generating a distinct and fast-growing revenue stream. The growing application of this life support modality is highlighted by global registry data; according to the Extracorporeal Life Support Organization, a cumulative total of 245,291 extracorporeal life support runs were recorded by April 2025, illustrating the deepening integration of these advanced technologies into critical care protocols.

Market Challenge

The Global Oxygenators Market currently contends with significant obstacles arising from rigorous regulatory frameworks for device approval and quality assurance. Although the clinical necessity for cardiopulmonary support is increasing, the intricate compliance standards required to launch these life-sustaining devices serve as a major bottleneck. Manufacturers are compelled to allocate substantial resources to satisfy these strict protocols, which drastically prolongs the timeline from product conception to market availability. This delay disrupts supply chains and prevents the timely delivery of advanced oxygenation technologies to healthcare providers.

Furthermore, the financial burden of these regulations establishes high barriers to entry that restrict broader market expansion. Companies must shoulder elevated development costs for extended periods without immediate revenue generation. According to MedTech Europe, the average time to certification for medical devices under current regulations was reported in 2024 to range between 13 and 18 months. This extended cycle discourages investment in new product development and places a disproportionate strain on smaller innovators lacking the capital to survive such lengthy review processes, ultimately retarding the sector's overall growth rate.

Market Trends

The market is being transformed by the emergence of smart oxygenators equipped with integrated sensor monitoring, which enhances clinical decision-making during complex perfusion procedures. By incorporating real-time sensing capabilities directly into the device, these systems provide continuous feedback on vital parameters such as oxygen saturation and line pressure without the need for external probes. This integration optimizes perfusionist workflows and boosts operational efficiency by minimizing the equipment footprint in operating theaters. The commercial success of these systems is reflected in LivaNova PLC's October 2024 results, where Cardiopulmonary segment revenue rose by 15.6%, driven largely by sales of the Essenz Perfusion System and its consumables.

Simultaneously, the adoption of Polymethyl Pentene (PMP) hollow fiber technology is replacing traditional polypropylene membranes, especially for extended life support applications. PMP fibers provide superior resistance to plasma leakage, allowing oxygenators to operate effectively for days instead of hours, which supports the increasing requirement for long-duration extracorporeal membrane oxygenation (ECMO). This material innovation fuels the demand for durable disposables, even during broader supply chain fluctuations. For instance, Getinge noted in its interim report for July-September 2024, released in October 2024, that there was particularly strong growth in consumables within its Cardiopulmonary business area, underscoring the sustained reliance on these advanced technologies for acute care.

Key Market Players

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific, Inc.
• Siemens Healthcare GmbH
• Bio-Rad Laboratories, Inc.
• Koninklijke Philips N.V.
• Toshiba Corporation
• Agilent Technologies, Inc.
• Illumina, Inc.
• Merck KGaADanaher Corporation

Report Scope

In this report, the Global Oxygenators Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oxygenators Market, By Product Type

• Bubble Oxygenator v/s Membrane Oxygenator

Oxygenators Market, By Type

• Adult Oxygenators v/s Pediatric Oxygenators

Oxygenators Market, By Application

• Respiratory
• Cardiac
• COVID-19
• Others

Oxygenators Market, By End User

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Oxygenators Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Oxygenators Market.

Available Customizations:

Global Oxygenators Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oxygenators Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Bubble Oxygenator v/s Membrane Oxygenator)
  • 5.2.2. By Type (Adult Oxygenators v/s Pediatric Oxygenators)
  • 5.2.3. By Application (Respiratory, Cardiac, COVID-19, Others)
  • 5.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Oxygenators Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Oxygenators Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Oxygenators Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Oxygenators Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Oxygenators Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Oxygenators Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Oxygenators Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Oxygenators Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Oxygenators Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Oxygenators Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Oxygenators Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Oxygenators Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Oxygenators Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Oxygenators Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Oxygenators Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Oxygenators Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Oxygenators Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Oxygenators Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Oxygenators Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Oxygenators Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Oxygenators Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Type
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Oxygenators Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Oxygenators Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Oxygenators Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Oxygenators Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. F. Hoffmann-La Roche Ltd.
• 15.3. Thermo Fisher Scientific, Inc.
• 15.4. Siemens Healthcare GmbH
• 15.5. Bio-Rad Laboratories, Inc.
• 15.6. Koninklijke Philips N.V.
• 15.7. Toshiba Corporation
• 15.8. Agilent Technologies, Inc.
• 15.9. Illumina, Inc.
• 15.10. Merck KGaADanaher Corporation

16. Strategic Recommendations

17. About Us & Disclaimer